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Chlamydia pneumoniae is recognized as a common cause 
of respiratory infection and is increasingly associated 
with a wide range of other conditions, including 
atherosclerosis [ 11. Although culture is rarely under- 
taken, isolates from the respiratory tract, coronary 
artery and other sites are available. However, somewhat 
paradoxically, the majority of epidemiologic data have 
been obtained serologically using the strains TW183 or 
IOL-207 as antigens, both of which were isolated from 
the eye [1,2]. 
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Figure 1 AFLP profiles of C. pneurnoniae strains NWL-1 
(N), VR1310 (v) and IOL-207 (I) showing bands present 
for NWL-1 and VR1310 at -500 bp and -1500 bp which 
are absent from IOL-207. DNA from purified C. pneurnoniae 
IOL-207 (Is) and C. trachornatis MoPn (M) elementary 
bodies and from uninfected BGMK cells (B) are included 
as controls. L denotes 100-bp DNA ladder and *denotes 
water blank. 
Although some workers maintain that C. pneumoniae 
is extremely homogeneous, others have demonstrated 
antigenic differences and have suggested that different 
strains may be responsible for distinct clinical manifesta- 
tions [1,3]. However, to date no significant dk5erences 
in the nucleotide sequences of a number of genes have 
been shown in C. pneumoniae strains isolated from a 
wide range of geographic locations [3]. 
Amplified fragment length polymorphism typing 
(AFLP), a recently described molecular typing method, 
is based on the selective PCR amplification of restriction 
fragments of the whole genome and has been shown to 
be rapid, reproducible and highly discriminatory [4]. 
Although it has been successfully applied to a wide range 
of genera, to date it has not been applied to Chlamydia. 
We recently isolated a strain of C .  pneumoniae 
(designated NWL-1) from the sputum of a 13-year-old 
female with a 2-week history of sore throat and 
purulent sputum production, who, after unsuccessful 
treatment with penicillin, responded to erythromycin 
treatment over a 2-week period. As this is, to our 
knowledge, the first stable UK isolate of C. pneumoniae, 
we were interested to see if, using AFLP, it was possible 
to distinguish it from other isolates, and we report here 
our preliminary data. 
C. pneumoniae isolates NWL-1, IOL-207 and 
VR13 10 were propagated in cycloheximide-treated 
Buffalo Green Monkey kidney (BGMK) cells and 
partially purified, and their DNA was extracted. In 
addition, DNAs from uninfected BGMK cells and from 
highly purified elementary bodies of C. pneumoniae 
IOL-207 and C. trucliomatis biovar mouse (MoPn) were 
used as controls. The AFLP method used was essentially 
as described by Valsangiacomo et al, and is a simplified 
version of the technique which utilizes only a single- 
step reaction and one restriction enzyme [5]. 
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Following digestion of the DNAs with PstI 
and ligation of the adapter, we examined the isolates 
using five PstI primers. Each primer was identical, 
5’-GACTGCGTACATGCAGB-3’, except for the 
selective 3’-terminal base B, representing either C, G, 
T, A or no additional base. We found that primer 
Prt I-T reproducibly discriminated the strains of C. 
prietrmoniae into two groups, one comprising NWL-1 
and VR1310 (both respiratory isolates) and the other 
comprising IOL-207 (an eye isolate) (Figure 1). 
These initial results clearly demonstrate differences 
between the respiratory and eye isolates. We now 
propose to examine a wider range of isolates with 
additional restriction enzymes to see if any correlation 
exists between type and clinical source. We would be 
pleased to receive any isolates of C. pmw/ioniae for 
further study using this technique. 
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